Ischemic optic neuropathy

Seminars in Neurology

Volumn 27, Issue 3, 2007, Pages 221-232

  Fontal, Monica Rodriguez ^a   Kerrison, John B ^a   Garcia, Reinaldo ^a   Oria, Veronica ^a  

^a Charleston Neuroscience Institute   (United States)

Author keywords

Arteritic; Nonarteritic; Optic neuropathy

Indexed keywords

AFFERENT PUPILLARY DEFECT; COLOR VISION DEFECT; DISEASE CLASSIFICATION; HUMAN; ISCHEMIC OPTIC NEUROPATHY; OPTIC NERVE ATROPHY; PAPILLEDEMA; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TEMPORAL ARTERITIS; VISUAL ACUITY; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

DIAGNOSIS, DIFFERENTIAL; HUMANS; OPTIC NEUROPATHY, ISCHEMIC; VISION DISORDERS;

EID: 34347333460     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979686     Document Type: Review

References (112)

1. Rucker JC, Biousse V, Newman NJ. Ischemic optic neuropathies. Curr Opin Neurol 2004;17:27-35
2. Onda E, Cioffi GA, Bacon DR, Van Buskirk EM. Microvasculature of the human optic nerve. Am J Ophthalmol 1995;120:92-102
3. Hayreh SS, Podhajsky PA, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997;123:285-296
4. Liu NH, LaBree LD, Feldon SE, Rao NA. The epidemiology of giant cell arteritis: a 12-year retrospective study. Ophthalmology 2001;108:1145-1149
5. Tomsak RL. Giant cell arteritis. Ophthalmology 2002;109: 219-220
6. Hayreh SS, Zimmerman B. Management of giant cell arteritis - our 27-year clinical study: new light on old controversies. Ophthalmologica 2003;217:239-259
7. Guyer DR, Miller NR, Auer CL, Fine SL. The risk of cerebrovascular and cardiovascular disease in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 1985; 103:1136-1142
8. Henkind P, Charles NC, Pearson J. Histopathology of ischemic optic neuropathy. Am J Ophthalmol 1970;69:78-90
9. Rootman J, Butler D. Ischaemic optic neuropathy: a combined mechanism. Br J Ophthalmol 1980;64:826-831
10. Nordborg E, Nordborg C. Giant cell arteritis: epidemiology clues to its pathogenesis and an update on its treatment. Rheumatology 2003;42:413-421
11. Liu GT, Glaser JS, Schatz NJ, Smith JL. Visual morbidity in giant cell arteritis. Ophthalmology 1994;101:1779-1785
12. Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG. Visual prognosis in giant cell arteritis. Ophthalmology 1993;100:550-555
13. Repka MX, Savino PJ, Schatz NJ, Sergott RC. Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol 1983;96:478-483
14. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestation of giant cell arteritis. Am J Ophthalmol 1998; 125:509-520
15. Hayreh SS. Anterior ischemic optic neuropathy: differentiation of arteritic from nonarteritic type and its management. Eye 1990;4:25-41
16. Siatkowski RM, Gass JD, Glaser JS, Smith JL, Schatz NJ, Schiffman J. Fluorescein angiography in the diagnosis of giant cell arteritis. Am J Ophthalmol 1993;115:57-63
17. Melberg NS, Grand MG, Dieckert PJ. Cotton-wool spots and the early diagnosis of giant cell arteritis. Ophthalmology 1995;102:1611-1614
18. Arnold AC, Hepler RS. Fluorescein angiography in acute nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994;117:222-230
19. Arnold AC, Badr MA, Hepler RS. Fluorescein angiography in nonischemic optic disc edema. Arch Ophthalmol 1996;114:293-298
20. Mack HG, O'Day J, Currie JN. Delayed choroidal perfusion in giant cell arteritis. J Clin Neuroophthalmol 1991;11:221-227
21. Hayreh SS, Podhajsky PA, Raman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol 1997;123:285-296
22. Jones JG, Hazleman BL. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis 1981;40:1-5
23. Miller A, Green M, Robinson D. Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed) 1983;286:266
24. Zweegman S, Makkink B, Stehouwer CD. Giant cell arteritis with normal erythrocyte sedimentation rate: case report and review of the literature. Neth J Med 1993;42: 128-131
25. Small JM, Gavrilescu K. The serum protein changes in giant cell arteritis. J Neurol Neurosurg Psychiatry 1963;26:257-261
26. Eshaghian J, Goeken JA. C-reactive protein in giant cell (cranial, temporal) arteritis. Ophthalmology 1980;87:1160-1166
27. Krishna R, Kosmorsky GS. Implications of thrombocytosis in giant cell arteritis. Am J Ophthalmol 1997;124:103
28. Liozon E, Herrmann F, Ly K, et al. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med 2001;111:211-217
29. Albert DM, Ruchman MC, Keltner JL. Skip lesion in temporal arteritis. Arch Ophthalmol 1976;94:2072-2077
30. McDonnell PJ, Moore GW, Miller NR, Hutchins GM, Green WR. Temporal arteritis: a clinicopathologic study. Ophthalmology 1986;93:518-530
31. Hunder GG, Sheps SG, Allen GL, Joyce JW. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study. Ann Intern Med 1975;82:613-618
32. Hedges TR 3rd, Gieger GL, Albert DM. The clinical value of negative temporal artery biopsy specimens. Arch Ophthalmol 1983;101:1251-1254
33. Guevara RA, Newman NJ, Grossniklaus HE. Positive temporal artery biopsy 6 months after prednisone treatment. Arch Ophthalmol 1998;116:1252-1253
34. Chan CC, Paine M, O'Day J. Steroid management in giant cell arteritis. Br J Ophthalmol 2001;85:1061-1064
35. Hayreh SS, Zimmerman B, Kardon RH. Visual improvement with corticosteroid therapy in giant cell arteritis: report of a large study and review of the literature. Acta Ophthalmol Scand 2002;80:355-367
36. Foroozan R, Deramo VA, Buono LM, et al. Recovery of visual function in patients with biopsy-proven giant cell arteritis. Ophthalmology 2003;110:539-542
37. Beri M, Klugman MR, Kohler JA, Hayreh SS. Anterior ischemic optic neuropathy: VII. Incidence of bilaterality and various influencing factors. Ophthalmology 1987;94:1020-1028
38. Miller NR, Keltner JL, Gittinger JW. Giant cell (temporal) arteritis: the differential diagnosis. Surv Ophthalmol 1979; 23:259-263
39. Hayreh SS, Zimmerman B. Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy. Ophthalmology 2003;110:1204-1215
40. Spiera RF, Mitnick HJ, Kupersmith M. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol 2001;19:495-501
41. Jover JA, Hernandez Garcia C, Morado IC, Vargas E, Banares A, Fernandez-Gutierrez B. Combined treatment of giant-cell arteritis with methotrexate and prednisone: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001;134:106-114
42. Hoffman GS, Cid MC, Hellmann DB, et al. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 2002;46:1309-1318
43. Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M. Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004;50:1332-1337
44. Weyand CM, Kaiser M, Yang H. Therapeutic effects of acetylsalicylic acid in giant cell arteritis. Arthritis Rheum 2002;46:457-466
45. Borruat FX, Herbort CP. Herpes zoster ophthalmicus: anterior ischemic optic neuropathy and acyclovir. J Clin Neuroophthalmol 1992;12:37-40
46. Isaak BL, Liesegang TJ, Michet CJ Jr. Ocular and systemic findings in relapsing polycondritis. Ophthalmology 1986;93: 681-689
47. Crompton JL, Iyer P, Begg MW. Vasculitis and ischaemic optic neuropathy associated with rheumatoid arthritis. Aust J Ophthalmol 1980;8:219-230
48. Hsu CT, Kerrison JB, Miller NR, Goldberg MF. Choroidal infarction, anterior ischemic optic neuropathy, and central retinal artery occlusion from polyarteritis nodosa. Retina 2001;21:348-351
49. Kattah JC, Chrousos GA, Katz PA, McCasland B, Kolsky MP. Anterior ischemic optic neuropathy in Churg-Strauss syndrome. Neurology 1994;44:2200-2202
50. Ischemic Optic Neuropathy Decompression Trial Research Group. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol 1996; 114:1366-1374
51. Hattenhauer MG, Leavitt JA, Hodge DO, Grill R, Gray DT. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997;123:103-107
52. Boghen DR, Glaser JS. Ischaemic optic neuropathy: the clinical profile and history. Brain 1975;98:689-708
53. Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994;118:766-780
54. Chutorian AM, Winterkorn JM, Geffner M. Anterior ischemic optic neuropathy in children: case report and review of the literature. Pediatr Neurol 2002;26:358-364
55. Rizzo JF III, Lessell S. Optic neuritis and ischemic optic neuropathy: overlapping clinical profiles. Arch Ophthalmol 1991;109:1668-1672
56. Swartz NG, Beck RW, Savino PJ, et al. Pain in anterior ischemic optic neuropathy. J Neuroophthalmol 1995;15:9-10
57. Cheng MA, Sigurdson W, Tempelhoff R, Lauryssen C. Visual loss after spine surgery: a survey. Neurosurgery 2000; 46:625-630
58. Boone MI, Massry GG, Frankel RA, Holds JB, Chung SM. Visual outcome in bilateral nonarteritic anterior ischemic optic neuropathy. Ophthalmology 1996;103:1223-1228
59. Olver JM, Spalton DJ, McCartney AC. Microvascular study of the retrolaminar optic nerve in man: the possible significance in anterior ischaemic optic neuropathy. Eye 1990;4:7-24
60. Jonas JB, Gusek GC, Naumann GO. Anterior ischemic optic neuropathy: nonarteritic form in small and giant cell arteritis in normal sized optic discs. Int Ophthalmol 1988; 12:119-125
61. Mansour AM, Shoch D, Logani S. Optic disk size in ischemic optic neuropathy. Am J Ophthalmol 1988;106: 587-589
62. Feit RH, Tomsak RL, Ellenberger C Jr. Structural factors in the pathogenesis of ischemic optic neuropathy. Am J Ophthalmol 1984;98:105-108
63. Beck RW, Savino PJ, Repka MX, Schatz NJ, Sergott RC. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology 1984;91:1334-1337
64. Doro S, Lessell S. Cup-disc ratio and ischemic optic neuropathy. Arch Ophthalmol 1985;103:1143-1144
65. Burde RM. Optic disk risk factors for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1993;116: 759-764
66. Hayreh SS, Zimmerman B. Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination. Arch Ophthalmol 2005;123:1554-1562
67. Arnold AC, Hepler RS. Natural history of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 1994; 14:66-69
68. Yee RD, Selky AK, Purvin VA. Outcomes of optic nerve sheath decompression for nonarteritic ischemic optic neuropathy. J Neuroophthalmol 1994;14:70-76
69. Sawle GV, James CB, Russell RW. The natural history of non-arteritic anterior ischaemic optic neuropathy. J Neurol Neurosurg Psychiatry 1990;53:830-833
70. Newman NJ, Scherer R, Langenberg P, et al. Ischemic Optic Neuropathy Decompression Trial Research Group. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002;134:317-328
71. Cheng MA, Sigurdson W, Tempelhoff R, Lauryssen C. Visual loss after spine surgery: a survey. Neurosurgery 2000; 46:625-630
72. Williams EL, Hart WM Jr, Tempelhoff R. Postoperative ischemic optic neuropathy. Anesth Analg 1995;80:1018-1029
73. Hayreh SS, Podhajsky PA, Zimmerman B. Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 2001;132:734-742
74. Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol 2003;23:157-163
75. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol 1994; 117:603-624
76. Landau K, Winterkorn JM, Mailloux LU, Vetter W, Napolitano B. 24-hour blood pressure monitoring in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 1996;114:570-575
77. Mojon DS, Hedges TR III, Ehrenberg B, et al. Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 2002;120: 601-605
78. Lee AG, Kohnen T, Ebner R, et al. Optic neuropathy associated with laser in situ keratomileusis. J Cataract Refract Surg 2000;26:1581-1584
79. Hayreh SS. Anterior ischemic optic neuropathy: IV. Occurrence after cataract extraction. Arch Ophthalmol 1980;98:1410-1416
80. Kim R, Van Stavern G, Juzych M. Nonarteritic anterior ischemic optic neuropathy associated with acute glaucoma secondary to Posner-Schlossman syndrome. Arch Ophthalmol 2003;121:127-128
81. Chiari M, Manzoni GC, Van de Geijn EJ. Ischemic optic neuropathy after sumatriptan in a migraine with aura patient. Headache 1994;34:237-238
82. Egan R, Pomeranz H. Sildenafil (Viagra) associated anterior ischemic optic neuropathy. Arch Ophthalmol 2000;118: 291-292
83. Hayreh SS. Erectile dysfunction drugs and non-arteritic anterior ischemic optic neuropathy: is there a cause and effect relationship? J Neuroophthalmol 2005;25:295-298
84. Nagra PK, Foroozan R, Savino PJ, Castillo I, Sergott RC. Amiodarone induced optic neuropathy. Br J Ophthalmol 2003;87:420-422
85. Fivgas GD, Newman NJ. Anterior ischemic optic neuropathy following the use of a nasal decongestant. Am J Ophthalmol 1999;127:104-106
86. Kerrison JB. Optic neuropathies caused by toxins and adverse drug reactions. Ophthalmol Clin North Am 2004; 17:481-488
87. Weger M, Stanger O, Deutschmann H, et al. Hyperhomocyst(e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy. Br J Ophthalmol 2001;85:803-806
88. Kawasaki A, Purvin VA, Burgett RA. Hyperhomocysteinaemia in young patients with non-arteritic anterior ischaemic optic neuropathy. Br J Ophthalmol 1999;83: 1287-1290
89. Biousse V, Kerrison JB, Newman NJ. Is non-arteritic anterior ischaemic optic neuropathy related to homocysteine? Br J Ophthalmol 2000;84:555
90. Salomon O, Huna-Baron R, Kurtz S, et al. Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy. Ophthalmology 1999;106:739-742
91. Knox DL, Kerrison JB, Green WR. Histopathologic studies of ischemic optic neuropathy. Trans Am Ophthalmol Soc 2000;98:203-220
92. Sergott RC, Cohen MS, Bosley TM, Savino PJ. Optic nerve decompression may improve the progressive form of non-arteritic ischemic optic neuropathy. Arch Ophthalmol 1989; 107:1743-1754
93. Spoor TC, Wilkinson MJ, Ramocki JM. Optic nerve sheath decompression for the treatment of progressive nonarteritic ischemic optic neuropathy. Am J Ophthalmol 1991;111: 724-728
94. Kelman SE, Elman MJ. Optic nerve sheath decompression for nonarteritic ischemic optic neuropathy improves multiple visual function measurements. Arch Ophthalmol 1991; 109:667-671
95. The Ischemic Optic Neuropathy Decompression Trial Research Group. Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful. JAMA 1995;273:625-632
96. Keltner JL, Becker B, Gay AJ, Podos SM. Effect of diphenylhydantoin in ischemic optic neuritis. Trans Am Ophthalmol Soc 1972;70:113-130
97. Ellenberger C Jr, Burde RM, Keltner JL. Acute optic neuropathy: treatment with diphenylhydantoin. Arch Ophthalmol 1974;91:435-438
98. Kollarits CR, McCarthy RW, Corrie WS, Swann ER. Norepinephrine therapy of ischemic optic neuropathy. J Clin Neuroophthalmol 1981;1:283-288
99. Smith JL. Norepinephrine therapy of ischemic optic neuropathy. J Clin Neuroophthalmol 1981;1:289-290
100. Johnson LN, Guy ME, Krohel GB, Madsen RW. Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2000; 107:521-526
101. Kupersmith MJ, Frohman L, Sanderson M, et al. Aspirin reduces the incidence of second eye NAION: a retrospective study. J Neuroophthalmol 1997;17:250-253
102. Salomon O, Huna-Baron R, Steinberg DM, Kurtz S, Seligsohn U. Role of aspirin in reducing the frequency of second eye involvement in patients with non-arteritic anterior ischaemic optic neuropathy. Eye 1999;13:357-359
103. Beck RW, Hayreh SS, Podhajsky PA, Tan ES, Moke PS. Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997;123:212-217
104. Soheilian M, Koochek A, Yazdani S, Peyman GA. Transvitreal optic neurotomy for nonarteritic anterior ischemic optic neuropathy. Retina 2003;23:692-697
105. Arnold AC, Levin LA. Treatment of ischemic optic neuropathy. Semin Ophthalmol 2002;17:39-46
106. Jonas JB, Spandau UH, Harder B, Sauder G. Intravitreal triamcinolone acetonide for treatment of acute nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2006; May 4(Epub ahead of print)
107. Sadda SR, Nee M, Miller NR, Biousse V, Newman NJ, Kouzis A. Clinical spectrum of posterior ischemic optic neuropathy. Am J Ophthalmol 2001;132:743-750
108. Hayreh SS. Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management. Eye 2004;18:1188-1206
109. Hayreh SS. Posterior ischemic optic neuropathy. Ophthalmologica 1981;182:29-41
110. Alexandrakis G, Lam BL. Bilateral posterior ischemic optic neuropathy after spinal surgery. Am J Ophthalmol 1999; 127:354-355
111. Marks SC, Jaques DA, Hirata RM, Saunders JR Jr. Blindness following bilateral radical neck dissection. Head Neck 1990;12:342-345
112. Rizzo JF III, Lessell S. Posterior ischemic optic neuropathy during general surgery. Am J Ophthalmol 1987;103:808-811